3 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
Follow volixibat: new trials by email Literature Review of volixibat trials Research Report on volixibat
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate How the Study Drug SHP626 is Eliminated From the Body After One Dose SHP626, 5.95 μCi RAD - Non-Alcoholic Steatohepatitis | Phase 1 | Completed | Mirum Pharmaceuticals, Inc. | 8 | 2015-10-01 | 2019-05-01 |
| Study to Assess the Relative Potency of Multiple Oral Doses of LUM001 and SHP626 in Overweight and Obese Adults as Assessed by Fecal Bile Acid Excretion Placebo, Maralixibat, Volixibat - Healthy Volunteers | Phase 1 | Completed | Mirum Pharmaceuticals, Inc. | 84 | 2015-06-01 | 2019-04-04 |
| Safety and Tolerability Study of SHP626 in Overweight and Obese Adults SHP626, Placebo - Non-Alcoholic Steatohepatitis | Phase 1 | Completed | Mirum Pharmaceuticals, Inc. | 84 | 2015-01-19 | 2019-03-26 |
Non-alcoholic Fatty Liver Disease (2)
Mirum Pharmaceuticals, Inc. (3)
United States (3)